Streetbeat News

Price Targets

MEOH

UBS analyst Joshua Spector has maintained a Neutral rating on Methanex Corporation (NASDAQ:MEOH) and increased the price target from $45 to $48.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:03 pm

EMN

UBS analyst Joshua Spector has maintained a Neutral rating on Eastman Chemical (NYSE:EMN) and increased the price target from $81 to $89.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 4:02 pm

TRIP

TripAdvisor (NASDAQ:TRIP) has received mixed analyst ratings in the last quarter, with 2 bullish, 1 indifferent, and 1 somewhat bearish rating. Over the past 3 months, 4 analysts have set a 12-month price target for TRIP, averaging $21.25, with a high of $25.00 and a low of $18.00. The average price target has seen a significant increase of 32.81% over the past month.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:00 pm

GDOT

Green Dot (NYSE:GDOT) has received mixed analyst ratings in the last quarter, with 2 bullish, 2 indifferent, and 1 somewhat bearish. The average 12-month price target from 5 analysts is $12.8, which is a 36.0% decrease from the previous target of $20.00. Ratings suggest analysts are divided on the stock's future performance.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:00 pm

YETI

YETI Holdings (NYSE:YETI) has received mixed analyst ratings in the last quarter, with 1 somewhat bullish, 4 indifferent, and 1 somewhat bearish rating. Over the past 3 months, 6 analysts have set a 12-month price target for YETI, with an average target of $45.83, a high of $57.00, and a low of $33.00. This average price target represents a 23.86% increase from the previous target of $37.00. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:00 pm

BAC

Bank of America (NYSE:BAC) has received a mix of analyst ratings in the last quarter, with 2 bullish, 3 somewhat bullish, 3 indifferent, and no bearish ratings. The average 12-month price target from 8 analysts is $40.12, with a high of $51.00 and a low of $30.00. This target has increased by 1.03% over the past month. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:00 pm

CTKB

Cytek Biosciences (NASDAQ:CTKB) received 4 analyst ratings in the last quarter, with 2 somewhat bullish and 2 indifferent, and no bearish ratings. The average 12-month price target is $8.5, with a high of $10.00 and a low of $7.00, marking a 29.17% decrease from the previous target of $12.00.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:00 pm

DOW

Over the past 3 months, 7 Wall Street analysts have provided ratings for Dow (NYSE:DOW), with 2 somewhat bullish and 5 indifferent, and no bearish ratings. The average 12-month price target for Dow is $55.14, with a high of $60.00 and a low of $52.00, representing a 2.11% decrease from the previous target of $56.33.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 4:00 pm

DOW

UBS analyst Joshua Spector has maintained a Neutral rating on Dow (NYSE:DOW) and increased the price target from $52 to $54.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 3:51 pm

CE

UBS analyst Joshua Spector has reaffirmed a Buy rating on Celanese Corporation (NYSE:CE) and increased the price target from $144 to $169, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 14, 2023 | 3:50 pm